US reclassifies some Marijuana products as less dangerous; hearing set for June 2026
Mint·4h ago·Neutral
What Happened
The US Department of Justice and DEA reclassified some marijuana products from Schedule I to Schedule III under federal drug laws, recognizing medical value and lower risk. Following Trump's executive order, officials announced a June 2026 hearing to decide full reclassification. The change enables marijuana research, eases regulatory burdens for cannabis businesses, and provides physicians better clinical information.
Key Entities
US Department of JusticeDEADonald TrumpTodd BlancheTerry ColeSchedule ISchedule IIIJune 2026